Bovine viral diarrhoea virus antigenic diversity: Impact on disease and vaccination programmes

Biologicals

Volumn 31, Issue 2, 2003, Pages 89-95

  Fulton, Robert W ^a   Ridpath, Julia F ^b   Confer, Anthony W ^a   Saliki, Jeremiah T ^a   Burge, Lurinda J ^a   Payton, Mark E ^a  

^a OKLAHOMA STATE UNIVERSITY   (United States)

^b AGRICULTURAL RESEARCH SERVICE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOVINE DIARRHEA VIRUS VACCINE; BOVISHIELD; UNCLASSIFIED DRUG; VIRUS VACCINE;

ANIMAL CELL; ANTIBODY TITER; ANTIGENIC VARIATION; BIOTYPE; BOVINE DIARRHEA VIRUS; CATTLE DISEASE; CONFERENCE PAPER; CONTROLLED STUDY; GENOTYPE; HEALTH PROGRAM; NONHUMAN; NUCLEOTIDE SEQUENCE; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; VACCINATION; VIRUS INFECTION; VIRUS ISOLATION; VIRUS STRAIN;

BOS TAURUS; BOVINAE; BOVINE VIRAL DIARRHEA VIRUS 1;

EID: 0037613724     PISSN: 10451056     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1045-1056(03)00021-6     Document Type: Conference Paper

References (15)

1. Baker J.C. The clinical manifestations of bovine viral diarrhea infection. Vet Clin North America. 11:1995;425-445.
2. Pellerin C., Vanden Hurk J., Lecomte J., Tijssen P. Identification of a new group of bovine viral diarrhea virus strains associated with severe outbreaks and high mortalities. Virology. 203:1994;260-268.
3. Ridpath J.F., Bolin S.R., Dubovi E. Segregation of bovine viral diarrhea virus into genotypes. Virology. 205:1994;66074.
4. Ridpath J.F., Bolin S.R. Differentiation of types 1a, 1b, and 2 bovine viral diarrhea virus (BVDV) by PCR. Molecular and Cellular Probes. 12:1998;101-106.
5. Jones L., Van Campen H., Zu Z.C., Schnackel J.A. Comparison of neutralizing antibodies to type 1a, 1b, and 2 bovine viral diarrhea virus from experimentally infected and vaccinated cattle. Bovine Practitioner. 35:2001;137-140.
6. Fulton R.W., Saliki J.T., Confer A.W., Burge L.J., d'Offay J.M., Helman R.G., et al. Bovine viral diarrhea virus cytopathic and noncytopathic biotypes and type 1 and 2 genotypes in diagnostic laboratory accessions: clinical and necropsy samples from cattle. J Vet Diagn Invest. 12:2000;33-38.
7. Deng R., Brock K.V. Molecular cloning and nucleotide sequence of a pestivirus genome, noncytopathic bovine viral diarrhea virus strain SD-1. Virology. 191:1989;867-869.
8. Agresti A. Categorical data analysis. 1990;66 John Wiley and Sons, New York (NY).
9. Fulton R.W., Confer A.W., Burge L.J., Perino L.J., d'Offay J.M., Payton M.E., et al. Antibody responses by cattle after vaccination with commercial viral vaccines containing bovine herpesvirus-1, bovine viral diarrhea virus, parainfluenza-3 virus and bovine respiratory syncytial virus immunogens and subsequent revaccination at day 140. Vaccine. 13:1995;725-733.
10. Fulton R.W., Burge L.J. Bovine viral diarrhea virus types 1 and 2 antibody response in calves receiving modified live virus or inactivated vaccines. Vaccine. 19:2000;267-274.
11. Fulton R.W., Saliki J.T., Burge L.J., d'Offay J.M., Bolin S.R., Maes R.K., et al. Neutralizing antibodies to type 1 and 2 bovine viral diarrhea viruses: detection by inhibition of viral cytopathology and infectivity by immunoperoxidase assay. Clin Diagn Immunol. 4:1997;380-383.
12. Compendium of veterinary products. 6th ed. Fort Huron (MI), 2001.
13. Cortese V.S., Grooms D.L., Ellis J., Colin S.R., Ridpath J.F., Brock K.V. Protection of pregnant cattle and their fetuses against infection with bovine viral diarrhea virus type 1 by use of a modified-live virus vaccine. Am J Vet Res. 59:1998;1409-1413.
14. Brock K.V., Cortese V.S. Experimental fetal challenge using type II bovine viral diarrhea virus in cattle vaccinated with modified-live virus vaccine. Veterinary Therapeutics. 2:2001;354-360.
15. Fulton R.W., Ridpath J.F., Saliki J.T., Briggs R.E., Confer A.W., Burge L.J., et al. Bovine viral diarrhea virus (BVDV) 1b: predominant BVDV subtype in calves with respiratory disease. Can J Vet Res. 66:2002;181-190.